SynthesisBreast cancer research and treatment2025

Efficacy and safety of abemaciclib plus endocrine therapy versus endocrine therapy alone in HR + and HER2-negative breast cancer; a systematic review and meta-analysis.

Khudija Sadia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.